Engaging cancer patients in genomic sequencing research
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
This study is all about finding better ways to connect with cancer patients and survivors, especially those from underrepresented groups, to help them get involved in research about their cancers, like cholangiocarcinoma and colorectal cancer in younger people, so we can learn more and improve care for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10924001 on NIH RePORTER |
What this research studies
The Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) focuses on improving how cancer patients and survivors, particularly those from understudied populations, are engaged in genomic research. This initiative aims to develop effective outreach and communication strategies that resonate with diverse cancer communities, especially for rare cancers like cholangiocarcinoma and colorectal cancer in younger patients. By collaborating with community and advocacy groups, the center seeks to create a supportive environment for patient participation in genomic studies, ultimately enhancing the understanding of these cancers. The research will utilize real-world settings to implement and evaluate these engagement strategies.
Who could benefit from this research
Good fit: Ideal candidates include cancer patients and survivors, particularly those with rare cancers or those diagnosed under the age of 50.
Not a fit: Patients with common cancers or those who are not interested in genomic research may not benefit from this initiative.
Why it matters
Potential benefit: If successful, this research could lead to improved participation of underrepresented cancer patients in genomic studies, enhancing personalized treatment options.
How similar studies have performed: Previous research has shown that tailored engagement strategies can significantly improve participation rates in clinical studies, suggesting a promising outlook for this approach.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Colditz, Graham a. — Washington University
- Study coordinator: Colditz, Graham a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.